Enovis (ENOV) Return on Capital Employed Growth (1y) (2012 - 2026)
Enovis (ENOV) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 252.00 |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -110.00 |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -231.00 |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 328.00 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 658.00 |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 200.00 |
| 10 | Enovis | 1.24 Bn | 1.21 Bn | 365.49 Mn | -1,498.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -1,498.00 |
| Dec 31, 2025 | -1,495.00 |
| Oct 3, 2025 | -2,864.00 |
| Jul 4, 2025 | -1,522.00 |
| Apr 4, 2025 | -1,653.00 |
| Dec 31, 2024 | -1,524.00 |
| Sep 27, 2024 | -18.00 |
| Jun 28, 2024 | 0.00 |
| Mar 29, 2024 | -4.00 |
| Dec 31, 2023 | 27.00 |
| Sep 29, 2023 | -48.00 |
| Jun 30, 2023 | -4.00 |
| Mar 31, 2023 | 13.00 |
| Dec 31, 2022 | -211.00 |
| Sep 30, 2022 | 30.00 |
| Jul 1, 2022 | -127.00 |
| Apr 1, 2022 | -95.00 |
| Dec 31, 2021 | 126.00 |
| Oct 1, 2021 | -507.00 |
| Jul 2, 2021 | -391.00 |